Abdominal Aortic Aneurysm

Company presents paper on its Powerlink stent graft

Published in Cardiovascular Week, February 14th, 2005

Endologix, Inc., (ELGX) announced that a clinical paper presented at the International Symposium for Endovascular Therapy (ISET) suggests that 3 years following treatment with the company's Powerlink System, patients (from the pivotal PMA [premarket approval] study) experienced decreases in aneurysm sac diameter and volume, and less angulation of the aorta.

The clinical paper, "Sac Remodeling with the Powerlink Stent Graft for AAA [abdominal aortic aneurysm]," was presented by Dr. Rodney White, professor of vascular surgery at Harbor-University of California at Los Angeles Medical Center, at ISET in Miami on January 19, 2005.

"These results are based...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cardiovascular Week

Source: Cardiovascular Week (2005-02-14)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry